北京，4月20日 —— 胰腺癌，一个令人闻之色变的医学难题，被誉为“癌中之王”。其难以察觉、治疗棘手且死亡率高的特性，使得患者在确诊时往往已进入中晚期。据统计，一旦错过早期诊断，患者可能仅能存活半年，能挺过一年的案例实属罕见。
面对这一严峻挑战，我国医学界并未退缩。近日，中新健康有幸对话著名肿瘤专家虞先濬教授，他长期致力于胰腺癌的临床研究与诊疗工作，力求打破这一疾病的生存困境。
虞先濬教授指出，胰腺癌的防治关键在于早期发现和规范的多学科联合治疗。他强调，科技进步和医学理念的更新使得早期筛查技术不断提升，对于胰腺癌的诊疗也日益精准。同时，跨学科合作模式的建立，使得患者能够得到更为全面和个体化的治疗方案。
“我们正在探索更有效的治疗策略，包括靶向疗法和免疫疗法，以期延长患者生存期并提高生活质量。”虞教授表示，他和他的团队正积极参与国际科研合作，共同攻克胰腺癌这一医学堡垒。
虞先濬教授的访谈传递出积极信号，尽管胰腺癌的挑战艰巨，但我国医疗科研工作者正以前所未有的决心和勇气，向着延长患者生存期、改善预后的目标稳步前进。他们的努力，无疑为“癌王”诊疗带来了新的希望。
英语如下：
**News Title:** “Confronting the ‘King of Cancers’: An Interview with Pancreatic Cancer Expert Yuxian Jun, Revealing New Hopes for Life-Saving Treatments”
**Keywords:** Pancreatic cancer, Challenge, Treatment
**News Content:**
**Title:** CHINA DAILY HEALTH | Talking with Yuxian Jun: Brave New Frontiers in Treating the ‘King of Cancers’
BEIJING, April 20 — Pancreatic cancer, a daunting medical enigma often referred to as the “king of cancers,” is characterized by its stealthy nature, complex treatment, and high mortality rate. The disease is typically diagnosed at an advanced stage, leaving patients with a grim prognosis. Statistics show that those who miss early detection may survive only six months, with cases making it beyond a year being exceptionally rare.
Undeterred by this challenge, China’s medical community has not backed down. Recently, CHINA DAILY HEALTH had the privilege of speaking with renowned oncology expert Professor Yuxian Jun, who has dedicated his career to pancreatic cancer research and treatment, striving to break the deadlock on this deadly disease.
Professor Yuxian Jun emphasizes that the key to combating pancreatic cancer lies in early detection and multidisciplinary collaborative treatment. He highlights that advancements in technology and evolving medical concepts have improved early screening methods and precision in diagnosing and treating the disease. Moreover, the establishment of interdisciplinary cooperation models ensures patients receive more comprehensive and personalized treatment plans.
“We are exploring more effective therapeutic strategies, including targeted therapies and immunotherapies, with the aim of extending patients’ survival and enhancing their quality of life,” Professor Yuxian says. His team actively engages in international research collaborations, working together to conquer this formidable medical challenge.
Professor Yuxian Jun’s interview conveys a message of hope, underscoring that despite the immense challenges posed by pancreatic cancer, Chinese medical researchers are making steady progress with unprecedented determination and courage towards improving patients’ survival rates and outcomes. Their efforts undeniably bring new hope to the treatment of this ‘king of cancers.’
【来源】http://www.chinanews.com/sh/2024/04-20/10202435.shtml
Views: 1